Mark B. Ulanja

673 total citations
43 papers, 422 citations indexed

About

Mark B. Ulanja is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark B. Ulanja has authored 43 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark B. Ulanja's work include Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Mark B. Ulanja is often cited by papers focused on Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Mark B. Ulanja collaborates with scholars based in United States, Ghana and India. Mark B. Ulanja's co-authors include Bryce D. Beutler, Nageshwara Gullapalli, Daniel Antwi‐Amoabeng, Olatunji B. Alese, Paschal Awingura Apanga, Maxwell Tii Kumbeni, Robert Akparibo, Jeanne Tie, Lavinia Tan and Natalie Cook and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgical Oncology.

In The Last Decade

Mark B. Ulanja

41 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark B. Ulanja United States 11 203 96 85 66 52 43 422
Güngör Utkan Türkiye 11 227 1.1× 94 1.0× 47 0.6× 26 0.4× 26 0.5× 61 412
Liisa Lyon United States 17 137 0.7× 32 0.3× 92 1.1× 33 0.5× 56 1.1× 43 606
Kathleen Coard Jamaica 17 103 0.5× 201 2.1× 86 1.0× 64 1.0× 33 0.6× 61 651
Janna Manjelievskaia United States 12 103 0.5× 67 0.7× 69 0.8× 52 0.8× 12 0.2× 39 420
E De Cock United Kingdom 15 172 0.8× 61 0.6× 49 0.6× 46 0.7× 10 0.2× 50 571
Amy Liu United States 13 234 1.2× 27 0.3× 71 0.8× 94 1.4× 25 0.5× 43 675
Akshay J. Patel United Kingdom 11 168 0.8× 127 1.3× 115 1.4× 27 0.4× 54 1.0× 78 485
Anya Burton United Kingdom 11 106 0.5× 61 0.6× 43 0.5× 29 0.4× 24 0.5× 22 472
Ron Thomas United States 10 202 1.0× 142 1.5× 67 0.8× 33 0.5× 78 1.5× 21 402

Countries citing papers authored by Mark B. Ulanja

Since Specialization
Citations

This map shows the geographic impact of Mark B. Ulanja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Ulanja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Ulanja more than expected).

Fields of papers citing papers by Mark B. Ulanja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Ulanja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Ulanja. The network helps show where Mark B. Ulanja may publish in the future.

Co-authorship network of co-authors of Mark B. Ulanja

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Ulanja. A scholar is included among the top collaborators of Mark B. Ulanja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Ulanja. Mark B. Ulanja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Beutler, Bryce D., et al.. (2024). Anti-N-methyl-D-aspartate receptor-associated encephalitis: A review of clinicopathologic hallmarks and multimodal imaging manifestations. World Journal of Radiology. 16(1). 1–8. 2 indexed citations
4.
Antwi‐Amoabeng, Daniel, Bryce D. Beutler, Sri Harsha Boppana, et al.. (2024). Incidental Coronary Artery Calcification and the Risk of Major Adverse Cardiovascular Outcomes. Cureus. 16(11). e73531–e73531. 1 indexed citations
6.
Nyarko, Emmanuel Karlo, et al.. (2023). Assessing knowledge and awareness of COVID-19 among traders and sanitary workers in the Cape Coast Metropolis of Ghana. SHILAP Revista de lepidopterología. 7. 1 indexed citations
7.
Antwi‐Amoabeng, Daniel, et al.. (2023). Association between Psychiatric Disorders and the Incidence of Heart Failure in Women. Journal of Cardiovascular Development and Disease. 10(12). 491–491. 3 indexed citations
9.
Antwi‐Amoabeng, Daniel, et al.. (2023). Association between histamine 2 receptor antagonists and sepsis outcomes in ICU patients: a retrospective analysis using the MIMI-IV database. SHILAP Revista de lepidopterología. 3(1). 3–3. 1 indexed citations
10.
Antwi‐Amoabeng, Daniel, et al.. (2022). Association between Empagliflozin Use and Electrocardiographic Changes. SHILAP Revista de lepidopterología. 12(4). 557–564. 3 indexed citations
11.
Antwi‐Amoabeng, Daniel, et al.. (2021). Association between electrocardiographic features and mortality in COVID‐19 patients. Annals of Noninvasive Electrocardiology. 26(4). e12833–e12833. 25 indexed citations
12.
Antwi‐Amoabeng, Daniel, et al.. (2021). Ponatinib-associated panniculitis: Case report and review of the literature. Cancer Treatment and Research Communications. 27. 100357–100357. 3 indexed citations
13.
Ulanja, Mark B., et al.. (2021). Cranial molding on neonates in Ghana: mothers’ perspective and their knowledge on potential harm to babies’ brain. Child s Nervous System. 37(5). 1703–1711. 1 indexed citations
14.
Apanga, Paschal Awingura, et al.. (2020). Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study. BMJ Open. 10(9). e041103–e041103. 45 indexed citations
15.
Nso, Nso, Daniel Antwi‐Amoabeng, Bryce D. Beutler, et al.. (2020). Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis. World Journal of Cardiology. 12(11). 584–598. 42 indexed citations
16.
Ulanja, Mark B., et al.. (2019). Randomized, double-blinded, placebo-controlled trial evaluating simethicone pretreatment with bowel preparation during colonoscopy. World Journal of Gastrointestinal Endoscopy. 11(6). 413–423. 9 indexed citations
17.
Ulanja, Mark B., Carrie Lyons, Sosthenes Ketende, et al.. (2019). The relationship between depression and sexual health service utilization among men who have sex with men (MSM) in Côte d'Ivoire, West Africa. BMC International Health and Human Rights. 19(1). 11–11. 21 indexed citations
18.
Ulanja, Mark B., et al.. (2019). Racial Disparity in Incidence and Survival for Gastrointestinal Stromal Tumors (GISTs): an Analysis of SEER Database. Journal of Racial and Ethnic Health Disparities. 6(5). 1035–1043. 17 indexed citations
19.
Ulanja, Mark B., et al.. (2018). Colorectal Cancer Presentation and Survival in Young Individuals: A Retrospective Cohort Study. Cancers. 10(12). 472–472. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026